The latest news of OPM are here

All Financial News Poster Press Release Scientific paper Uncategorized
Filter by :
4th Letter to Shareholders
News
Press Release
Mon. 6 January 2025

4th Letter to Shareholders

Read more
OPM reacquires rights to its OPM-201 program from Servier after a positive Phase I trial in healthy volunteers
News
Press Release
Fri. 20 December 2024

OPM reacquires rights to its OPM-201 program from Servier after a positive Phase I trial in healthy volunteers

Read more
OPM reports final results of its phase 1 study with RIPK2 inhibitor OPM-101
News
Press Release
Tue. 22 October 2024

OPM reports final results of its phase 1 study with RIPK2 inhibitor OPM-101

Read more
OPM announces poster presentation on OPM-101
News
Press Release
Tue. 15 October 2024

OPM announces poster presentation on OPM-101

Read more
OPM announces its first-half 2024 results and provides an update on its clinical developments, and its financial situation
Financial
News
Press Release
Wed. 25 September 2024

OPM announces its first-half 2024 results and provides an update on its clinical developments, and its financial situation

Read more
OPM announces positive results of phase 1 healthy volunteers of OPM-101
News
Press Release
Tue. 16 July 2024

OPM announces positive results of phase 1 healthy volunteers of OPM-101

Read more
Letter to the shareholders n°3
Financial
News
Press Release
Mon. 24 June 2024

Letter to the shareholders n°3

Read more
OPM and Navigo Proteins GmbH sign a strategic collaboration agreement for the research and development of new systemic radiotherapy agents
News
Press Release
Wed. 15 May 2024

OPM and Navigo Proteins GmbH sign a strategic collaboration agreement for the research and development of new systemic radiotherapy agents

Read more
Degroof Petercam initiates coverage of Oncodesign Precision Medicine
Financial
News
Press Release
Thu. 18 April 2024

Degroof Petercam initiates coverage of Oncodesign Precision Medicine

Read more